Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Boehringer Ingelheim
Boehringer Ingelheim
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Novartis
Janssen Research & Development, LLC
National Cancer Institute (NCI)
7 Hills Pharma, LLC
National Cancer Institute (NCI)
Bristol-Myers Squibb
Parabilis Medicines, Inc.
Genmab
National Institutes of Health Clinical Center (CC)
Verastem, Inc.
Novartis
Revolution Medicines, Inc.
Ipsen
Recurv Pharma Inc
University of Chicago
Revolution Medicines, Inc.
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
Blue Earth Diagnostics
National Institutes of Health Clinical Center (CC)
Erasca, Inc.
Eisai Inc.
Tianjin Medical University Cancer Institute and Hospital
GlaxoSmithKline
Alentis Therapeutics AG
Artios Pharma Ltd
Novartis
Frontier Medicines Corporation
Roswell Park Cancer Institute
Elicio Therapeutics
BioNTech SE
Massachusetts General Hospital
PMV Pharmaceuticals, Inc
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Betta Pharmaceuticals Co., Ltd.
HonorHealth Research Institute
M.D. Anderson Cancer Center
BioNTech SE
Akeso
National Cancer Institute (NCI)
Neonc Technologies, Inc.
Icahn School of Medicine at Mount Sinai
Institut du Cancer de Montpellier - Val d'Aurelle
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sichuan Enray Pharmaceutical Sciences Company
Children's Oncology Group
A2 Biotherapeutics Inc.